Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis

Estarreja, João; Mendes, Priscila; Silva, Carina; Camacho, Pedro; Mateus, Vanessa

http://hdl.handle.net/10400.21/16721

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Correction_The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf		20.19 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

[This corrects the article DOI: 10.2196/38658.]

Keywords

Ophthalmology Age-related macular degeneration Bevacizumab Drug therapy nAMD Neovascular age-related macular degeneration Wet macular degeneration

URI

http://hdl.handle.net/10400.21/16721

Citation

Estarreja J, Mendes P, Silva C, Camacho P, Mateus V. Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2023;12:e50411.